High flow nasal cannula use is associated with increased hospital length of stay for pediatric asthma
Pediatric Pulmonology · 2023
DOI: 10.1002/ppul.26617 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Pulmonology, 2023. Verfasst von Colin Rogerson und 7 weiteren Autor:innen. Beteiligte Einrichtung: Indiana University School of Medicine, Indianapolis, Indiana, USA. Hauptthemen laut MEDLINE: Asthma, Noninvasive Ventilation, Respiratory Insufficiency. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, AHRQ HHS, Indiana University.
Abstract (Originalsprache)
Background
High flow nasal cannula (HFNC) is a respiratory device increasingly used to treat asthma. Recent mechanistic studies have shown that nebulized medications may have reduced delivery with HFNC, which may impair asthma treatment. This study evaluated the association between HFNC use for pediatric asthma and hospital length of stay (LOS).
Methods
This was a retrospective matched cohort study. Cases included patients aged 2–18 years hospitalized between January 2010 and December 2021 with asthma and received HFNC treatment. Controls were selected using logistic regression propensity score matching based on demographics, vital signs, medications, imaging, and social and environmental determinants of health. The primary outcome was hospital LOS.
Results
A total of 23,659 encounters met eligibility criteria, and of these 1766 cases included HFNC treatment with a suitable matched control. Cases were well‐matched in demographics, social and environmental determinants of health, and clinical characteristics including use of adjunctive asthma therapies. The median hospital LOS for study cases was significantly higher at 87 h (interquartile range [IQR]: 61–145) compared to 66 h (IQR: 43–105) in the matched controls ( p < 0.01). There was no significant difference in the rate of intubation and mechanical ventilation (8.9% vs. 7.6%, p = .18); however, the use of NIV was significantly higher in the cases than the control group (21.3% vs. 6.7%, p < .01).
Conclusion
In this study of children hospitalized for asthma, HFNC use was associated with increased hospital LOS compared to matched controls. Further research using more granular data and additional relevant variables is needed to validate these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Department of Biostatistics, Indiana University-Purdue University, Indianapolis, Indiana, USA.
- Regenstrief Institute, Center for Biomedical Informatics, Indianapolis, Indiana, USA.
- Cincinnati Children's Hospital and Medical Center, Cincinnati, Ohio, USA.
ORCID-Profile: Colin Rogerson
Förderung
- NHLBI NIH HHS
- AHRQ HHS
- Indiana University
Zitieren
APA
Rogerson, C., Owora, A., He, T., Carroll, A., Schleyer, T., AbuSultaneh, S., Tu, W., & Mendonca, E. (2023). High flow nasal cannula use is associated with increased hospital length of stay for pediatric asthma. Pediatric Pulmonology. https://doi.org/10.1002/ppul.26617
Vancouver
Rogerson C, Owora A, He T, Carroll A, Schleyer T, AbuSultaneh S, et al. High flow nasal cannula use is associated with increased hospital length of stay for pediatric asthma. Pediatric Pulmonology. 2023. doi:10.1002/ppul.26617
BibTeX
@article{Rogerson2023,
author = {Rogerson, Colin and Owora, Arthur and He, Tian and Carroll, Aaron and Schleyer, Titus and AbuSultaneh, Samer and Tu, Wanzhu and Mendonca, Eneida},
title = {High flow nasal cannula use is associated with increased hospital length of stay for pediatric asthma},
journal = {Pediatric Pulmonology},
year = {2023},
doi = {10.1002/ppul.26617}
}
EUVIMED